"Resolving Patent Disputes with Risk Analysis," presented to the Damages and Litigation Committees at the Intellectual Property Owners (IPO) 2007 Annual Meeting
This event has already occurred.
Related Insights
Pembrolizumab Patent IPR Final Written Decision Issued and Director Review Requested